330 related articles for article (PubMed ID: 12497547)
1. Phaeohyphomycotic infections in solid organ transplant patients.
Garcia-Diaz JB; Baumgarten K
Semin Respir Infect; 2002 Dec; 17(4):303-9. PubMed ID: 12497547
[TBL] [Abstract][Full Text] [Related]
2. Fungal infections in solid organ transplant recipients.
Hadley S; Karchmer AW
Infect Dis Clin North Am; 1995 Dec; 9(4):1045-74. PubMed ID: 8747778
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi.
Brandt ME; Warnock DW
J Chemother; 2003 Nov; 15 Suppl 2():36-47. PubMed ID: 14708965
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic antifungal agents used after lung transplantation.
Marino E; Gallagher JC
Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients].
López-Medrano F; Díaz-Pedroche C; Lumbreras C; Aguado JM
Rev Esp Quimioter; 2005 Mar; 18(1):14-20. PubMed ID: 15915227
[TBL] [Abstract][Full Text] [Related]
6. [Fungal infections in transplantation patients].
Colomba C; Antinori S
Recenti Prog Med; 2003 Nov; 94(11):516-28. PubMed ID: 14679922
[TBL] [Abstract][Full Text] [Related]
7. Fungal infections in solid organ transplantation.
Silveira FP; Husain S
Med Mycol; 2007 Jun; 45(4):305-20. PubMed ID: 17510855
[TBL] [Abstract][Full Text] [Related]
8. Fungal infection in solid organ recipients.
Fortún J; Ruiz I; Martín-Dávila P; Cuenca-Estrella M
Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():49-56. PubMed ID: 22542035
[TBL] [Abstract][Full Text] [Related]
9. Changing strategies for the management of invasive fungal infections.
Rapp RP
Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Salavert M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
[TBL] [Abstract][Full Text] [Related]
11. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
Husain S; Alexander BD; Munoz P; Avery RK; Houston S; Pruett T; Jacobs R; Dominguez EA; Tollemar JG; Baumgarten K; Yu CM; Wagener MM; Linden P; Kusne S; Singh N
Clin Infect Dis; 2003 Jul; 37(2):221-9. PubMed ID: 12856215
[TBL] [Abstract][Full Text] [Related]
12. [Emerging visceral mycoses].
Morin O
Rev Prat; 2001 Apr; 51(7):742-6. PubMed ID: 11387670
[TBL] [Abstract][Full Text] [Related]
13. Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?
Muñoz P; Singh N; Bouza E
Curr Opin Infect Dis; 2006 Aug; 19(4):365-70. PubMed ID: 16804385
[TBL] [Abstract][Full Text] [Related]
14. Non-Aspergillus fungal pneumonia in transplant recipients.
Costa SF; Alexander BD
Clin Chest Med; 2005 Dec; 26(4):675-90, vii. PubMed ID: 16263405
[TBL] [Abstract][Full Text] [Related]
15. [Prevention and treatment of fungal infections in solid-organ transplant recipients].
Muñoz P; Bouza E
Rev Clin Esp; 1995 Oct; 195 Suppl 3():38-48. PubMed ID: 9441304
[No Abstract] [Full Text] [Related]
16. Prevention and treatment of fungal infections in bone marrow transplantation.
Mossad SB
Curr Hematol Rep; 2003 Jul; 2(4):302-9. PubMed ID: 12901327
[TBL] [Abstract][Full Text] [Related]
17. Antifungal prophylaxis in lung transplantation.
Avery RK
Semin Respir Crit Care Med; 2011 Dec; 32(6):717-26. PubMed ID: 22167399
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system phaeohyphomycosis: a review of 101 cases.
Revankar SG; Sutton DA; Rinaldi MG
Clin Infect Dis; 2004 Jan; 38(2):206-16. PubMed ID: 14699452
[TBL] [Abstract][Full Text] [Related]
19. Changing epidemiology of systemic fungal infections.
Richardson M; Lass-Flörl C
Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
[TBL] [Abstract][Full Text] [Related]
20. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Metcalf SC; Dockrell DH
J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
